Loading...
Loading...
Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings, Inc.. Spoken Alpha tracks CDIO's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks CDIO's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 9/10 quarters with 50% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 4 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Spoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for CDIO.
curl https://api.spokenalpha.com/v1/companies/CDIO| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $2.57 | $2.25 | +14.3% | +1.4% | +2.1% |
| Q4 FY2026 | $2.35 | $2.37 | -0.9% | -4.0% | -3.7% |
| Q3 FY2026 | $2.75 | $2.44 | +12.5% | +5.2% | +6.6% |
| Q2 FY2026 | $2.71 | $2.39 | +13.4% | +6.1% | +7.9% |
| Q1 FY2025 | $2.51 | $2.31 | +8.8% | -3.7% | -2.4% |
| Q4 FY2025 | $2.45 | $2.28 | +7.5% | +4.5% | +6.1% |
| Q3 FY2025 | $2.33 | $2.33 | +0.2% | -1.7% | -2.8% |
| Q2 FY2025 | $2.59 | $2.41 | +7.5% | -1.7% | -4.5% |
| Q1 FY2024 | $2.55 | $2.47 | +3.2% | -2.7% | -2.8% |
| Q4 FY2024 | $2.43 | $2.39 | +1.5% | +1.7% | -0.4% |
OTHER_C_SUITE since 2024 • 3/8 beats (38%) • guidance suspended Q1 FY2026